What Role Do Genomic Assays Play In The Decision To Extend Endocrine Therapy

What Role Do Genomic Assays Play in the Decision to Extend Endocrine Therapy?

Breast Cancer Index

What Genomic Assay is Best Suited for the Extended Endocrine Therapy Decision?

Breast Cancer Index

Genomic Assays Impact Treatment Decisions in Patients With ER+ Breast Cancer

Targeted Oncology

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast Cancer

Total Health | Oncology

Impact of genomic testing on treatment decision-making in breast cancer

Education Session: Trends in Adjuvant Endocrine Therapy

San Antonio Breast Cancer Symposium

Consideration of Side Effects in Extended Endocrine Therapy Decision Making

Breast Cancer Index

Standardizing Extended Endocrine Therapy Recommendations

Breast Cancer Index

Challenges With Patient Selection for Extended Adjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Genomic Testing in Breast Cancer: What You Must Know

Breast Cancer School for Patients

Hormonal Therapy for Breast Cancer: We Teach You

Breast Cancer School for Patients

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Genomic Assays and Breast Cancer

Rocky Mountain Cancer Centers

Live CMB: Genomic assays in the neoadjuvant setting: are we ready yet? Extended hormone therapy.

Câncer de Mama Brasil

JADPRO Live 2023 - Standardizing Extended Endocrine Therapy Decision-Making

Breast Cancer Index

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

Utilizing Genomic Assays for Decision Making in Early Stage Breast Cancer

Targeted Oncology

Genomic Testing During Breast Cancer: Should You Have Testing?

Yerbba – Breast Cancer

Does 21-gene recurrence score assay testingchange decisions? Dr. Adher Alsayed ( Day 1)

Oncology Events